75 related articles for article (PubMed ID: 6512561)
21. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
[TBL] [Abstract][Full Text] [Related]
22. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
23. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
25. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.
Magagnoli M; Castagna L; Balzarotti M; Sarina B; Timofeeva I; Bertuzzi A; Compasso S; Nozza A; Siracusano L; Santoro A
Am J Hematol; 2003 Aug; 73(4):267-72. PubMed ID: 12879431
[TBL] [Abstract][Full Text] [Related]
27. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ
Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126
[TBL] [Abstract][Full Text] [Related]
28. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
30. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
[TBL] [Abstract][Full Text] [Related]
31. Alfa interferon: combinations with other antineoplastic modalities.
Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
[TBL] [Abstract][Full Text] [Related]
32. Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis.
Lazzarino M; Vitale A; Morra E; Gagliardi A; Bernasconi P; Torromeo C; Inverardi D; Burgio V; Castello A; Bernasconi C
Br J Haematol; 1989 Jun; 72(2):173-7. PubMed ID: 2757963
[TBL] [Abstract][Full Text] [Related]
33. Combined use of interferon alpha-2, chlorambucil and prednisone in previously treated patients with low-grade non-Hodgkin's lymphomas. Results of a phase II study.
Molica S; Tucci L; Levato D; Levato L; Manfredi L
Tumori; 1993 Jun; 79(3):195-7. PubMed ID: 8236503
[TBL] [Abstract][Full Text] [Related]
34. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
Chisesi T; Capnist G; Vespignani M; Dini E
Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691
[No Abstract] [Full Text] [Related]
35. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
36. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
Scarffe JH; Wagstaff J; Crowther D
Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
[No Abstract] [Full Text] [Related]
37. A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia-lymphoma.
Ezaki K; Hirano M; Ohno R; Yamada K; Naito K; Hirota Y; Shirakawa S; Kimura K
Cancer; 1991 Aug; 68(4):695-8. PubMed ID: 1855169
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
Takeyama H; Yano K; Kataoka T; Watanabe E; Kobayashi M; Ohno R
Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
[No Abstract] [Full Text] [Related]
39. The interferons in haematological malignancies.
Mandelli F; Arcese W; Avvisati G
Baillieres Clin Haematol; 1994 Mar; 7(1):91-113. PubMed ID: 7518713
[TBL] [Abstract][Full Text] [Related]
40. High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS).
Ahre A; Björkholm M; Osterborg A; Brenning G; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Juliusson G; Järnmark M
Eur J Haematol; 1988 Aug; 41(2):123-30. PubMed ID: 3410007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
